TherapeuticsMD (TXMD) Other Non Operating Income (2011 - 2023)
TherapeuticsMD (TXMD) posted Other Non Operating Income of $359000.0 for Q3 2023, up 248.54% on a QoQ basis from $103000.0 in Q2 2023, and up 420.54% year-over-year from $68967.4 in Q3 2022.
TherapeuticsMD (TXMD) Other Non Operating Income (2011 - 2023) Analysis & Trends
TherapeuticsMD's Other Non Operating Income history runs 12 years deep, the most recent figure standing at $359000.0 for Q3 2023.
- Quarterly Other Non Operating Income rose 420.54% year-over-year to $359000.0 in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $880000.0 (up 110.33% YoY) and the FY2022 annual result came in at -$117000.0, down 143.01% from the prior year.
- Other Non Operating Income was $359000.0 for Q3 2023 at TherapeuticsMD, up from $103000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $703662.0 in Q3 2019 and bottomed at -$11.9 million in Q4 2019.
- A 5-year average of -$1.4 million and a median of $89000.0 in 2020 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2022 — Other Non Operating Income sank 6985.25% — and 2023, when it jumped 743.75%.
- TherapeuticsMD's Other Non Operating Income stood at -$11.9 million in 2019, then surged by 101.11% to $132000.0 in 2020, then slumped by 93.94% to $8000.0 in 2021, then soared by 37.5% to $11000.0 in 2022, then jumped by 3163.64% to $359000.0 in 2023.
- Business Quant data shows TXMD's Other Non Operating Income at $359000.0 in Q3 2023, $103000.0 in Q2 2023, and $407000.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | TherapeuticsMD | 280,159.99 | -8.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 359,000.00 |
| Jun 30, 2023 | 103,000.00 |
| Mar 31, 2023 | 407,000.00 |
| Dec 31, 2022 | 11,000.00 |
| Sep 30, 2022 | -112,000.00 |
| Jun 30, 2022 | -16,000.00 |
| Mar 31, 2022 | -8.40 Mn |
| Dec 31, 2021 | 8,000.00 |
| Sep 30, 2021 | 19,000.00 |
| Jun 30, 2021 | 123,000.00 |
| Mar 31, 2021 | 122,000.00 |
| Dec 31, 2020 | 132,000.00 |
| Sep 30, 2020 | 42,000.00 |
| Jun 30, 2020 | 89,000.00 |
| Mar 31, 2020 | 335,000.00 |
| Dec 31, 2019 | -11.94 Mn |
| Sep 30, 2019 | 703,662.00 |
| Jun 30, 2019 | -10.10 Mn |
| Mar 31, 2019 | 688,721.00 |
| Dec 31, 2018 | 823,027.00 |